The Patent Finder

Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor

Epizyme, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application PCT/US2013/036193, filed Apr 11, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,394,283Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
In force
 · High confidence
UsedRemaining
Epizyme, Inc.In forceHigh confidence
US 9,872,862Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
In force
 · High confidence
Epizyme, Inc.In forceHigh confidence
US 10,245,269Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
In force
 · High confidence
Epizyme, Inc.In forceHigh confidence
US 10,821,113Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
In force
 · High confidence
Epizyme, Inc.In forceHigh confidence
US 11,491,163Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
In force
 · High confidence
Epizyme, Inc.In forceHigh confidence
US 12,251,386Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
In force
 · High confidence
Epizyme, Inc.In forceHigh confidence
Application 19/053,007Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor
Pending
Not granted
Eisai R&D Management Co., Ltd.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Epizyme, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited